Advances in artificial intelligence (AI) have the potential to dramatically accelerate the rate at which compounds are identified and optimized. But has AI lived up to that potential? A partnership between Charles River and Valo Health, along with an ongoing collaboration between Flagship’s Pioneering Medicines, identified a potential therapeutic for lupus using Logica®, an AI-powered drug discovery platform. The power to leveraging the power of Logica to advance this program into lead optimization.
Join this webinar to hear the journey from early-stage drug discovery to advanceable candidate. This partnership represents a bold commitment to revolutionizing the drug discovery process by integrating scientific excellence and cutting-edge AI-driven technology.
This approach has a 90% success rate in producing advanceable lead series. We provide more insight into your leads by leveraging the power of hundreds of in vitro and in vivo models and thousands of computational predictive models We’ll also conduct an advancability assessment and leverage our data generation and compute capabilities to rapidly advance to a candidate.
Key Learning Objectives
- Strategic approach leveraging AI to expedite drug discovery
- Purpose-built AI with experimental confirmation
- Collaborative risk-sharing model
